ES2113338T3 - Clonado molecular y expresion de il-3 humano. - Google Patents

Clonado molecular y expresion de il-3 humano.

Info

Publication number
ES2113338T3
ES2113338T3 ES87202566T ES87202566T ES2113338T3 ES 2113338 T3 ES2113338 T3 ES 2113338T3 ES 87202566 T ES87202566 T ES 87202566T ES 87202566 T ES87202566 T ES 87202566T ES 2113338 T3 ES2113338 T3 ES 2113338T3
Authority
ES
Spain
Prior art keywords
produced
expression
human
molecular cloning
cadn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87202566T
Other languages
English (en)
Spanish (es)
Inventor
Lambertus Christiaan Dorssers
Gerard Dr Wagemaker
Yvonne Johanna Vos
Leen Robert Willem Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Application granted granted Critical
Publication of ES2113338T3 publication Critical patent/ES2113338T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES87202566T 1986-12-16 1987-12-16 Clonado molecular y expresion de il-3 humano. Expired - Lifetime ES2113338T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP86202285 1986-12-16
EP87201322 1987-07-13

Publications (1)

Publication Number Publication Date
ES2113338T3 true ES2113338T3 (es) 1998-05-01

Family

ID=26103432

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87202566T Expired - Lifetime ES2113338T3 (es) 1986-12-16 1987-12-16 Clonado molecular y expresion de il-3 humano.

Country Status (14)

Country Link
JP (2) JPH01502157A (fr)
AT (1) ATE161882T1 (fr)
AU (1) AU617095B2 (fr)
CA (1) CA1341503C (fr)
DE (1) DE3752158T2 (fr)
ES (1) ES2113338T3 (fr)
FI (1) FI102293B1 (fr)
GR (1) GR3025857T3 (fr)
IE (1) IE81129B1 (fr)
IL (1) IL84852A (fr)
NO (1) NO180544C (fr)
NZ (1) NZ222939A (fr)
PT (1) PT86381B (fr)
WO (1) WO1988004691A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
US6238889B1 (en) 1986-12-16 2001-05-29 Dsm N.V. Molecular cloning and expression of the Pro8 isoform of human IL-3
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".
US5304637A (en) * 1987-07-13 1994-04-19 Gist-Brocades N.V. Expression and purification of human interleukin-3 and muteins thereof
GB2210883B (en) * 1987-10-08 1992-01-02 British Bio Technology Synthetic interleukin-3 gene
US6384194B1 (en) 1987-12-16 2002-05-07 Dsm N.V. Expression and purification of human interleukin-3 and muteins thereof
JPH04500508A (ja) * 1988-07-20 1992-01-30 イミュネックス・コーポレーション 非グリコシル化　ヒト　インターロイキン―３　組成物
NZ232913A (en) * 1989-03-15 1992-08-26 Gist Brocades Nv Il-3 produced recombinantly and purified to homogeneity; vectors and pharmaceutical preparations
US5128450A (en) * 1989-06-30 1992-07-07 Urdal David L Nonglycosylated human interleukin-3 analog proteins
EP0413383B1 (fr) 1989-08-14 1997-06-18 Gist-Brocades N.V. Mutants de l'interleukine-3
US5516512A (en) 1989-08-14 1996-05-14 Gist-Brocades, N.V. N- and C-terminal truncation and deletion mutants of human interleukin-3
DK0596881T3 (da) * 1991-08-01 1997-10-13 Fond Nat Transfusion Sanguine Ekspression i ikke-tumurale humane lymofoblastoider med en integrativ vektor
ATE238421T1 (de) * 1992-11-24 2003-05-15 Searle & Co Interleukin-3 (il-3)-polypeptide mith mehreren mutationen
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
WO1999041382A2 (fr) * 1998-02-17 1999-08-19 Hyseq, Inc. Nouvelle interleukine 3 et ses utilisations
JP2008527981A (ja) * 2005-01-25 2008-07-31 アポロ ライフ サイエンシズ リミテッド 治療目的および診断目的のためにパラメーターにより選択されたｇｍ−ｃｓｆ、ｉｌ−３、ｉｌ−４、ｉｌ−５、ならびにそのキメラ
EP2001905A1 (fr) * 2006-04-03 2008-12-17 New England Biolabs, Inc. Expression, sécrétion et épuration d'albumine sérique bovine recombinante (rbsa) et ses utilisations
WO2024033522A1 (fr) 2022-08-11 2024-02-15 Universitätsklinikum Regensburg Anticorps ciblant il3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695542A (en) * 1983-10-04 1987-09-22 Dnax Research Institute Of Molecular And Cellular Biology, Inc. cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
AU570762B2 (en) * 1983-12-23 1988-03-24 Australian National University, The Cloning of cdna for il-3
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors

Also Published As

Publication number Publication date
JPH01502157A (ja) 1989-08-03
NO883614L (no) 1988-08-12
NO883614D0 (no) 1988-08-12
WO1988004691A1 (fr) 1988-06-30
DE3752158D1 (de) 1998-02-12
FI102293B (fi) 1998-11-13
NZ222939A (en) 1991-03-26
PT86381B (pt) 1990-11-20
IL84852A (en) 1994-06-24
FI102293B1 (fi) 1998-11-13
JPH1080286A (ja) 1998-03-31
AU617095B2 (en) 1991-11-21
GR3025857T3 (en) 1998-04-30
FI883688L (fi) 1988-08-08
IL84852A0 (en) 1988-06-30
AU1057788A (en) 1988-07-15
IE81129B1 (en) 2000-03-22
ATE161882T1 (de) 1998-01-15
IE873409L (en) 1988-06-12
CA1341503C (fr) 2006-04-04
NO180544C (no) 1997-05-07
DE3752158T2 (de) 1998-05-20
PT86381A (en) 1988-01-01
FI883688A0 (fi) 1988-08-08
NO180544B (no) 1997-01-27

Similar Documents

Publication Publication Date Title
ES2113338T3 (es) Clonado molecular y expresion de il-3 humano.
Trinchieri et al. Response of resting human peripheral blood natural killer cells to interleukin 2.
ES8506089A1 (es) Un procedimiento para preparar una celula u organismo recombinante
ES2130120T3 (es) Procedimiento para la preparacion de la adnasa humana.
ES2153444T3 (es) Anticuerpos contra interleucina-4 mamifera, y peptidos utiles como antigenos en su produccion.
ES2179351T3 (es) Amidas acidas de piridil alqueno y piridil alquino como citoestaticos e inmunosupresores.
ES2007341A6 (es) Un procedimiento para producir m-csf
SE8501709D0 (sv) Improvements in or relating to intrleukin therapy
IT8467445A1 (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea.
NO873244D0 (no) Legemiddel.
ATE105296T1 (de) Glycosylierte insulin-derivate.
ES8700258A1 (es) Procedimiento para la obtencion de poli-hidro piridazo dia- cepinas triacepinas o diazocinas
FI885807L (fi) Puhdistetun, biologisesti aktiivisen, bakteerien avulla tuotetun rekombinanttisen ihmis- CSF-1:n tuottaminen
PT93458A (pt) Processo para a preparacao e purificacao de interleuquina-3 humana recombinante das suas muteinas e de composicoes farmaceuticas que as contem
FR2598433B1 (fr) Procede de production d'interleukine-2 humaine, interleukine-2 ainsi obtenue, son utilisation a titre de medicament et composition pharmaceutique la contenant
BR8700576A (pt) Composicao,com hidrolise e cura,provendo um revestimento,membro revestido e refletor para aumentar a quantidade de luz util
ES2169080T3 (es) Inhibidor de la agregacion de plaquetas estimulada por colageno.
ES2057004T3 (es) N-alcoxialquilamidas de hidroxiacidos y composiciones a base de las mismas para el tratamiento de la piel.
ATE77048T1 (de) Bioemulgatoren enthaltende kosmetische und pharmazeutische zusammensetzungen.
ES2037709T3 (es) Derivados heterociclicos de seis miembros de n,n'-diacilhidrazinas n'-sustituidas.
ES2180550T3 (es) Moleculas receptoras de la hormona de glycoproteina.
MX168061B (es) Hidrolizado de proteinas mejorado
ES2086409T3 (es) Imidazolinas sustituidas en posicion 2 y preparacion y uso de las mismas.
FR2362848A1 (fr) Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques
ES2034239T3 (es) Purificacion de gm-csf.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 275598

Country of ref document: ES